Medical Article

Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two molecules that bring different mechanisms of action to suppressing HIV. The post FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral…

The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is worried about their heart rhythm at two o’clock in the morning. The post Wearable Noise Is Exploding — Trust Is the Filter appeared first on MedCity News.

Healthcare interoperability isn’t an abstract concept; it’s about human connection, building trust and easing burden on patients and their care providers.  The post Trust, Technology and the Future of Interoperability: Solving Problems That Impact Real Lives appeared first on MedCity News.

At the annual Medicarians conference in Las Vegas that draws brokers, agents, agency owners and field marketing organizations, among others, Dawn Maroney suggested that payers are not always the “bad guys.” The post Alignment Health Plan CEO: Sometimes When MA Plan is Pulling Out, the Provider is to Blame appeared first on MedCity News.

Oscar Health launched Lucie, a marketplace aimed at making healthcare more shoppable. The post Oscar Health Seeks to Build ‘Airbnb for Healthcare’ with New Marketplace, CEO Says appeared first on MedCity News.

Tortugas Neurosciences’ two lead programs are in-licensed oral small molecules in development for schizophrenia and tinnitus. The startup is led by veterans of Sage Therapeutics, a neuroscience biotech that was acquired last year. The post Neuro Startup Tortugas Unveils $106M and a Pipeline of Drugs for the Brain appeared first on MedCity News.

By using AI-powered intelligence to shift clinical and coding validation earlier in the healthcare continuum, and unlocking upstream clinical data to inform downstream payment workflows, organizations can proactively prevent errors, reduce downstream churn and friction, and support more predictable, accurate, and timely payments.  The post The Next Era of Payment Integrity: Earlier Clinical Validation, True…

What matters just as much — if not more — is everything around that number: how customers adopt the product, how sales actually happen, and whether the company is building something that can scale inside a complex, regulated system. The post Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching Instead appeared…